GMSS Holdings, LLC, the parent company of Geriatric Medical & Surgical Supply, LLC (“Geriatric Medical”), announces that it has acquired DDP Medical Supply (“DDP”), a leading distributor of medical and diabetic supplies. The acquisition significantly expands GMSS Holdings’ footprint, forming one of the nation’s leading medical supply distribution networks focused on chronic, post-acute, and home […]
You are unauthorized to view this page. Username Password Remember Me Forgot Password
Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of NMS Capital (“NMS”), announces that it has expanded internationally via a partnership with FAMECO Group ApS (“FAMECO” or the “Company”). Founded in 2000 and headquartered in Strasbourg, France, FAMECO is an international leader in the sale and refurbishment of analytical laboratory and medical equipment. Servicing over
You are unauthorized to view this page.
Patterson Invests in Business in the U.S. and U.K. Read More »
Patterson Companies, Inc. (Nasdaq: PDCO) a leading distribution company in the dental and animal health industries, announces that it has signed two separate acquisition agreements for its Animal Health business – Infusion Concepts in the United Kingdom and Mountain Vet Supply in the United States. Patterson’s U.K. animal health business, National Veterinary Services Limited (NVS),
Patterson Invests in Business in the U.S. and U.K. Read More »
You are unauthorized to view this page.
Why Drug Distributors Are Buying Cancer Specialists Read More »
Drug middlemen are duking it out to buy their customers. Most Americans pick up their prescription drugs at the local pharmacy, but many pricey medications are bought directly by medical providers. Think, for example, of a chemotherapy infusion delivered at a doctor’s office. The intermediaries selling drugs to those doctors run a pretty good business.
Why Drug Distributors Are Buying Cancer Specialists Read More »
Citing fears of vertical integration and reduced competition, anti-monopoly advocacy group American Economic Liberties Project and a small cadre of other advocacy organizations are urging federal regulators to block two recent oncology practice network deals. The purchases in question are McKesson Corporation’s $2.5 billion bid for a controlling stake in the Florida Cancer Specialists &
